TSC22D3 and colitis: These results are again sustained by those of Cannarile and collaborators who demonstrated in GILZ overexpressing transgenic mice that the reduced susceptibility to DNBS colitis is associated with the inhibition of NF-κB activation and the resulting reduction in IL-1β and TNF-α expression [35].